Compass Therapeutics, Inc. CMPX 深 沪
等待开盘 08-02 09:30:00 美东时间
2.95
-0.020
-0.67%
华盛通- 最 高2.97
- 今 开2.90
- 成交量 81.53万股
- 最 低 2.8001
- 昨 收 2.97
- 总市值 4.07亿
- 52周最高 4.08
- 市盈率 静 --
- 换手率 0.59%
- 52周最低 1.12
- 委 比 10.51%
- 总股本 1.38亿
- 历史最高 5.65
- 量 比 1.29
- 振 幅 5.72%
- 历史最低 0.765
- 每 手 1
- 风险率 0.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Raymond James Reinstates Outperform on Compass Therapeutics, Announces $9 Price Target
Raymond James analyst Sean McCutcheon reinstates Compass Therapeutics (NASDAQ:CMPX) with a Outperform and announces $9 price target.
07-01 23:42
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
Compass Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, at 11:05 – 11:35 AM ET. The chat will be available for replay on Compass’ Events page for 90 days. The company specializes in developing antibody-based therapeutics targeting critical biological pathways related to angiogenesis, immune response, and tumor growth. Head...
05-28 12:00
Compass Therapeutics Q1 EPS $(0.12) Misses $(0.11) Estimate
Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 50 percent decrease over losses of $(0.08) per share
05-08 20:15
32位与64位系统的主要区别在哪？
安装Win10时，选择32位还是64位系统，取决于电脑配置及是否支持。这并非随心所欲的选择，而是需要结合实际情况决定。如果电脑支持64位系统，却选择安装32位...
04-30 17:33
Guggenheim Reiterates Buy on Compass Therapeuticsto Buy
Guggenheim analyst Michael Schmidt reiterates Compass Therapeutics (NASDAQ:CMPX) from Buy to Buy.
04-22 21:21
美股大行评级 | 潜在涨幅3020.12%！Ascendiant Capital上调Plus Therapeutics目标价至20美元，维持"买入"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
04-22 08:41
美股机会日报丨全球市场遭遇“黑色星期一”；降息有转机？美联储闭门会议今夜召开
全球市场遭遇“黑色星期一”；美股三大期指跌幅收窄，特斯拉跌超5%，英伟达跌近4%；降息有转机？美联储将于今日举行闭门会议>>
04-07 20:40
